NCT05591053

Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

UNKNOWNNAINTERVENTIONAL

Trial Details

Start: 2023-04-01Est. Completion: 2025-01

Enrollment target: 70 participants

Locations

University of Pittsburgh Medical Center - Dept of Cardiothoracic Surgery, Pittsburgh, Pennsylvania, United States
West Penn Hospital / Allegheny Health Network, Pittsburgh, Pennsylvania, United States

Contact

Peter Kim, MDpkim@activsurgical.com 2023202750

Chris McCulloh, MDcmcculloh@activsurgical.com 617-333-8162

Other microbiome trials you might be interested in

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaPhase 2Recruiting

Esophageal CancerGastric (Stomach) CancerGastric AdenocarcinomaGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaEsophageal CarcinomaGastric (Cardia, Body) Cancer

Purpose of the Study: This clinical study investigates whether a shorter or longer duration of systemic therapy before …

Amsterdam, NetherlandsEst. completion Nov 2031

View Trial →

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerPhase 2Recruiting

Metastatic Esophageal Adenocarcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.